Cargando…
Safety profile of the transcription factor EB (TFEB)-based gene therapy through intracranial injection in mice
Transcription factor EB (TFEB)-based gene therapy is a promising therapeutic strategy in treating neurodegenerative diseases by promoting autophagy/lysosome-mediated degradation and clearance of misfolded proteins that contribute to the pathogenesis of these diseases. However, recent findings have s...
Autores principales: | Li, Zhenyu, Ding, Guangqian, Wang, Yudi, Zheng, Zelong, Lv, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711953/ https://www.ncbi.nlm.nih.gov/pubmed/33335764 http://dx.doi.org/10.1515/tnsci-2020-0132 |
Ejemplares similares
-
The Transcription Factor EB (TFEB) Sensitizes the Heart to Chronic Pressure Overload
por: Wundersitz, Sebastian, et al.
Publicado: (2022) -
The post‐translational regulation of transcription factor EB (TFEB) in health and disease
por: Takla, Michael, et al.
Publicado: (2023) -
Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease
por: Spampanato, Carmine, et al.
Publicado: (2013) -
Autophagy Activation by Transcription Factor EB (TFEB) in Striatum of HD(Q175/Q7) Mice
por: Vodicka, Petr, et al.
Publicado: (2016) -
Novel Insight into Functions of Transcription Factor EB (TFEB) in Alzheimer’s Disease and Parkinson’s Disease
por: Yang, Jing, et al.
Publicado: (2023)